These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30635292)

  • 21. Quality standards for the management of bronchiectasis in Italy: a national audit.
    Aliberti S; Hill AT; Mantero M; Battaglia S; Centanni S; Lo Cicero S; Lacedonia D; Saetta M; Chalmers JD; Blasi F;
    Eur Respir J; 2016 Jul; 48(1):244-8. PubMed ID: 27076581
    [No Abstract]   [Full Text] [Related]  

  • 22. Is there a role for antimicrobial stewardship in bronchiectasis?
    Gassiep I; Chaudhuri A
    Chron Respir Dis; 2015 Aug; 12(3):274-5. PubMed ID: 26015462
    [No Abstract]   [Full Text] [Related]  

  • 23. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.
    Burr LD; Rogers GB; Chen AC; Hamilton BR; Pool GF; Taylor SL; Venter D; Bowler SD; Biga S; McGuckin MA
    Ann Am Thorac Soc; 2016 Oct; 13(10):1697-1703. PubMed ID: 27464029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchiectasis with secondary pulmonary infection in a child: A case report.
    Zhu T; Gu H; Vinturache A; Ding G; Lu M
    Medicine (Baltimore); 2020 Sep; 99(39):e22475. PubMed ID: 32991486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudomonas aeruginosa infections in chronic obstructive pulmonary disease : Role of long-term antibiotic treatment].
    Rohde GGU; Welte T
    Internist (Berl); 2017 Nov; 58(11):1142-1149. PubMed ID: 28983645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa.
    Orriols R; Roig J; Ferrer J; Sampol G; Rosell A; Ferrer A; Vallano A
    Respir Med; 1999 Jul; 93(7):476-80. PubMed ID: 10464834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How does Pseudomonas aeruginosa affect the progression of bronchiectasis?
    Chai YH; Xu JF
    Clin Microbiol Infect; 2020 Mar; 26(3):313-318. PubMed ID: 31306794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic obstructive pulmonary disease and bronchiectasis.
    Novosad SA; Barker AF
    Curr Opin Pulm Med; 2013 Mar; 19(2):133-9. PubMed ID: 23287285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological Progress in Patients with Bronchial Infection with Pseudomonas aeruginosa Treated with Nebulised Colistin.
    Bruguera-Àvila N; Garcia-Olive I; Marin A; Prat C; Lacoma A; Gil M; Abad Capa J
    Respiration; 2019; 97(6):501-507. PubMed ID: 30605912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of systemic antibiotic in preventing sequential endogenous endophthalmitis of a bronchiectasis patient.
    Chan WM; Liu DT; Fan DS; Lau TT; Lam DS
    Am J Ophthalmol; 2005 Mar; 139(3):549-50. PubMed ID: 15767074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
    Scheinberg P; Shore E
    Chest; 2005 Apr; 127(4):1420-6. PubMed ID: 15821224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azithromycin inhibits the production of MUC5AC in the airway mucosa of patients with bronchiectasis induced by Pseudomonas aeruginosa.
    Wang J; Xu L; Lv Y; Sun L
    Pak J Pharm Sci; 2021 May; 34(3(Special)):1179-1185. PubMed ID: 34602387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
    VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J
    Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatigue in bronchiectasis.
    Hester KL; Macfarlane JG; Tedd H; Jary H; McAlinden P; Rostron L; Small T; Newton JL; De Soyza A
    QJM; 2012 Mar; 105(3):235-40. PubMed ID: 22016379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchiectasis Guidelines-Recommendations Into Practice.
    Redondo M; Chalmers JD
    Arch Bronconeumol (Engl Ed); 2019 Jun; 55(6):286-288. PubMed ID: 30981551
    [No Abstract]   [Full Text] [Related]  

  • 37. TAP deficiency is also a cause of bronchiectasis.
    Zimmer J; Sleiman M; Poli A; Michel T; Hentges F
    Thorax; 2013 May; 68(5):490-1. PubMed ID: 23299963
    [No Abstract]   [Full Text] [Related]  

  • 38. Bronchiectasis: When the Published Scientific Evidence Proves Insufficient.
    Martinez-Garcia MA; de la Rosa D; Cantón R; Olveira C; Máiz-Carro L; Girón R; Prados C; Blanco M
    Arch Bronconeumol (Engl Ed); 2019 Jun; 55(6):283-285. PubMed ID: 31203840
    [No Abstract]   [Full Text] [Related]  

  • 39. Pseudomonas aeruginosa-induced toxic enteritis (Pseudomonas enteritis) in a postoperative patient with sigmoid colon cancer and bronchiectasis associated with antibiotic and H2-blocker administration.
    Morita H; Murata Y; Yamamoto M; Kobori O; Nozato H
    Am J Gastroenterol; 1995 Aug; 90(8):1370. PubMed ID: 7639268
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on non-cystic fibrosis bronchiectasis.
    Bilton D
    Curr Opin Pulm Med; 2008 Nov; 14(6):595-9. PubMed ID: 18812838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.